ECM
NMTR

ExodusPoint Capital Management’s 9 Meters Biopharma NMTR Stock Holding History

ExodusPoint Capital Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,630
Closed -$42K – 2745
2021
Q3 		$42K Buy
+1,630
New +$38.4K ﹤0.01% 1982
2021
Q2 		– Sell
-14,809
Closed -$347K – 2960
2021
Q1 		$347K Buy
14,809
+12,504
+542% +$384K 0.01% 1574
2020
Q4 		$40K Sell
2,305
-6,700
-74% -$112K ﹤0.01% 1882
2020
Q3 		$147K Buy
+9,005
New +$109K ﹤0.01% 1550

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ExodusPoint Capital Management's NMTR Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of 9 Meters Biopharma (NMTR) in Q4 2021, closing a stake of 1,630 shares — an estimated $42K sold.

ExodusPoint Capital Management first reported a position in NMTR in Q3 2020 and held it in 4 quarters. The position peaked at $347K in Q1 2021. 104 funds tracked by Wall St. Rank hold NMTR as of Q4 2021.

  • ExodusPoint Capital Management reported no remaining 9 Meters Biopharma position as of Q4 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 1,630 9 Meters Biopharma shares in Q4 2021, an estimated $42K.
  • ExodusPoint Capital Management first reported a position in 9 Meters Biopharma in Q3 2020 and held it in 4 quarters.
  • ExodusPoint Capital Management's 9 Meters Biopharma position peaked at $347K in Q1 2021.
  • 104 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.